Metabolic Versatility of Mycobacterium tuberculosis during Infection and Dormancy

( ), the causative agent of tuberculosis (TB), is a highly successful intracellular pathogen with the ability to withstand harsh conditions and reside long-term within its host. In the dormant and persistent states, the bacterium tunes its metabolism and is able to resist the actions of antibiotics....

Full description

Saved in:
Bibliographic Details
Published in:Metabolites 2021-02, Vol.11 (2), p.88
Main Authors: Chang, Dorothy Pei Shan, Guan, Xue Li
Format: Article
Language:English
Subjects:
Antibiotics
Carbon
Cholesterol
Dormancy
Drug delivery
Drug development
Drug metabolism
Drug resistance
Drugs
Enzymes
Fatty acids
Gene expression
infection
Infections
Lipid metabolism
Lipids
Metabolic networks
Metabolic pathways
Metabolism
Metabolites
Mutation
Mycobacterium tuberculosis
Nutrients
Oxidative metabolism
Oxidative phosphorylation
Pathogens
Phosphorylation
Review
systems biology
Tuberculosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:( ), the causative agent of tuberculosis (TB), is a highly successful intracellular pathogen with the ability to withstand harsh conditions and reside long-term within its host. In the dormant and persistent states, the bacterium tunes its metabolism and is able to resist the actions of antibiotics. One of the main strategies adopts is through its metabolic versatility-it is able to cometabolize a variety of essential nutrients and direct these nutrients simultaneously to multiple metabolic pathways to facilitate the infection of the host. further undergo extensive remodeling of its metabolic pathways in response to stress and dormancy. In recent years, advancement in systems biology and its applications have contributed substantially to a more coherent view on the intricate metabolic networks of With a more refined appreciation of the roles of metabolism in mycobacterial infection and drug resistance, and the success of drugs targeting metabolism, there is growing interest in further development of anti-TB therapies that target metabolism, including lipid metabolism and oxidative phosphorylation. Here, we will review current knowledge revolving around the versatility of in remodeling its metabolism during infection and dormancy, with a focus on central carbon metabolism and lipid metabolism.
ISSN:2218-1989
2218-1989
DOI:10.3390/metabo11020088